CAR-pNK Cell Immunotherapy

· PersonGen BioTherapeutics (Suzhou) Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for CAR-pNK Cell Immunotherapy, covering 2016-12-06 to 2016-12-06. Get the full timeline:

Most recent: Clinical Trial Update: CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma [Phase 1, Phase 2]